No recent analyst price targets found for CHMMF.
Latest News for CHMMF

Chimeric Therapeutics secures FDA Orphan Drug Designation for CHM CDH17 in gastric cancer
Chimeric Therapeutics Ltd (ASX:CHM, OTC:CHMMF) has received Orphan Drug Designation from the US Food and Drug Administration (FDA) for its CHM CDH17 cell...
Proactive Investors - Finance • Dec 8, 2025

Imugene secures FDA backing for Azer-cel registration pathway
Imugene Ltd (ASX:IMU, OTC:IUGNF) has won crucial backing from the US Food and Drug Administration (FDA), with written minutes from a recent Type C meeting...
Proactive Investors - Finance • Dec 8, 2025

Kairos Minerals secures mining agreement with Nyamal Aboriginal Corporation for Mt York Gold Project
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) has signed a Mining Agreement with Nyamal Aboriginal Corporation (NAC) covering the Mt York Gold Project in the...
Proactive Investors - Finance • Dec 8, 2025
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CHMMF.
Senate Trading
No Senate trades found for CHMMF.
U.S. House Trading
No House trades found for CHMMF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
